Cyclopharma will be at ISRS 2017 in Dresden 14-19 May

CYCLOPHARMA is pleased to announce participation at 2017 International Symposium Radiopharmaceutical Sciences (ISRS)
May 14 – 19 in Dresden, Germany.

Scientific posters will be presented on innovative R&D projects in which the company is actively involved :

Radiosynthesis of the first [18F]-Nanocyclix® TKI-PET radiotracer targeting activated EGFR positive lung tumors
#18F # PET #TKI
Poster presentation (P187)
Abstract #601
by Dr. Christine Vala (CYCLOPHARMA, Tours, France)
Tuesday May 16, 2017, Poster Session II, 5:30 PM – 6:30 PM

Radiosynthesis and biological evaluation of 18F alpha7 radiotracers
#18F #alpha7 #PET
Poster presentation (P054)
Abstract #86
by Dr. Johnny Vercouillie (CERRP, Tours, France)
Monday May 15, 2017, Poster Session I, 5:30 PM – 6:30 PM

Synthesis and biological characterization of [18F]-OT14 and [18F]-OT15 as radioligands to image the vesicular acetylcholine transporters (VAChT)
#PET #VAChT
Poster presentation (P056)
Abstract #303
by Dr. Johnny Vercouillie (CERRP, Tours, France)
Monday May 15, 2017, Poster Session I, 5:30 PM – 6:30 PM

Conception and evaluation of new fluorinated COX-2 ligands to visualize and quantify neuroinflammation by PET
#18F #COX-2 #PET
Poster presentation (P207)
Abstract #121
by Dr. Johnny Vercouillie (CERRP, Tours, France)
Tuesday May 16, 2017, Poster Session II, 5:30 PM – 6:30 PM